Product Details
Product Details
Product Specification
| Antibody Type | ADC |
| Isotype | Human IgG1, κ |
| Isotype Control | Invivo human IgG1 isotype control |
| Concentration | 1 mg/ml |
| Purity | >95% (Determined by SDS-PAGE) |
| Endotoxin | <1EU/mg |
| Physical Appearance | Liquid |
| Storage Buffer | Reconstitute the Belantamab mafodotin using 0.9% Sodium Chloride Injection |
| Stability & Storage |
2 to 8 °C for 2 weeks under sterile conditions; -20 °C for 3 months under sterile conditions; -80 °C for 24 months under sterile conditions. Please avoid repeated freeze-thaw cycles. |
Background
Belantamab mafodotin (GSK2857916) is composed of humanized and focused monoclonal antibody against B cell maturation antigen (BCMA) and McMMAF. Belantamab mafodotin has anti-myeloma activity.
